DEN230002 is an FDA 510(k) submission (not cleared) for the DuraGraft. Classified as Flushing Solution For Short Term Storage Of Veins At Room Temperature During Coronary Artery Bypass Graft Surgeries (product code QEJ), Class II - Special Controls.
Submitted by Marizyme, Inc. (Jupiter, US). The FDA issued a Not Cleared (DENG) decision on October 4, 2023 after a review of 274 days.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4100 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: Regulatory edge-case submission. Elevated predicate reliance profile. With 274 days under review and no clearance granted, this submission reflects a case where the FDA could not confirm sufficient predicate equivalence - often indicating either a novel device category or unresolved safety and performance questions.
View all Marizyme, Inc. devices